Clinical trials referenced in this document:
Documents that mention this clinical trial
Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial
Funding for this research was provided by:
WHO (TES 2017_1071_001)
Ministry of Health of Gabon
Received: 14 May 2019
Accepted: 20 November 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: The National Ethics Committee (CNE) of Gabon (PRO 0017/2017/SG/CNE) and the institutional ethic committee of CERMEL (CEI 004/2017) approved the study protocol as well as the WHO Ethical review committee. The study protocol was explained to the parent or legal guardian and written informed consent was obtained before participant inclusion.
: Not applicable.
: The authors declare that they have no competing interests.